NEM

Quick Update for Newmont (NEM) Investors

More and more people are talking about Newmont over the last few weeks. Is it worth buying the Gold stock at a price of $42.34? Only time will tell. The information below will give you a basic idea of what this investment may entail:

  • Newmont has moved -21.1% over the last year, and the S&P 500 logged a change of -15.4%

  • NEM has an average analyst rating of buy and is -35.22% away from its mean target price of $65.35 per share

  • Its trailing earnings per share (Eps) is $0.94

  • Newmont has a trailing 12 month Price to Earnings (P/E) ratio of 45.0 while the S&P 500 average is 15.97

  • Its forward earnings per share (Eps) is $0.94 and its forward P/E ratio is 14.2

  • The company has a Price to Book (P/B) ratio of 1.6 in contrast to the S&P 500's average ratio of 2.95

  • Newmont is part of the Basic Materials sector, which has an average P/E ratio of 8.57 and an average P/B of 1.86

  • NEM has reported YOY quarterly earnings growth of -39.9% and gross profit margins of 36.6%

  • The company has a free cash flow of $1,846,125,056.00, which refers to the total sum of all its inflows and outflows of cash over the last quarter

  • Newmont Corporation engages in the production and exploration of gold. It also explores for copper, silver, zinc, and lead. The company has operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, and Ghana. As of December 31, 2021, it had proven and probable gold reserves of 92.8 million ounces and land position of 62,800 square kilometers. The company was founded in 1916 and is headquartered in Denver, Colorado.

At Market Interference, our goal is to help educate investors about headline-making stocks. We believe informed investment decisions are good investment decisions. subscribe to our free newsletter to stay on top of each day's market movements!

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS